SG11202009389QA - Use of nw_003613638.1 in cho cell genome for stable expression of protein - Google Patents
Use of nw_003613638.1 in cho cell genome for stable expression of proteinInfo
- Publication number
- SG11202009389QA SG11202009389QA SG11202009389QA SG11202009389QA SG11202009389QA SG 11202009389Q A SG11202009389Q A SG 11202009389QA SG 11202009389Q A SG11202009389Q A SG 11202009389QA SG 11202009389Q A SG11202009389Q A SG 11202009389QA SG 11202009389Q A SG11202009389Q A SG 11202009389QA
- Authority
- SG
- Singapore
- Prior art keywords
- protein
- cho cell
- cell genome
- stable expression
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811274637.4A CN109295092B (en) | 2018-10-30 | 2018-10-30 | Application of NW _003613638-1 stable expression protein in CHO cell genome |
PCT/CN2019/112451 WO2020088300A1 (en) | 2018-10-30 | 2019-10-22 | Use of nw_003613638-1 in cho cell genome for stable protein expression |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202009389QA true SG11202009389QA (en) | 2020-10-29 |
Family
ID=65158149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202009389QA SG11202009389QA (en) | 2018-10-30 | 2019-10-22 | Use of nw_003613638.1 in cho cell genome for stable expression of protein |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN109295092B (en) |
SG (1) | SG11202009389QA (en) |
WO (1) | WO2020088300A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109295092B (en) * | 2018-10-30 | 2021-06-29 | 江南大学 | Application of NW _003613638-1 stable expression protein in CHO cell genome |
CN113969284B (en) * | 2021-11-23 | 2022-07-12 | 江南大学 | Site for stably expressing protein in CHO cell gene NW _003614889.1 and application thereof |
CN113969283B (en) * | 2021-11-23 | 2022-07-12 | 江南大学 | Site for stably expressing protein in CHO cell gene NW _003613756.1 and application thereof |
CN114058625B (en) * | 2021-11-25 | 2022-07-15 | 江南大学 | Site for stably expressing protein in CHO cell gene NW _003613781.1 and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA037255B1 (en) * | 2014-10-23 | 2021-02-26 | Регенерон Фармасьютикалз, Инк. | Novel cho integration sites and uses thereof |
US10982191B2 (en) * | 2016-04-25 | 2021-04-20 | Danmarks Tekniske Universitet | Engineered mammalian cells for production of recombinant proteins |
US20210309988A1 (en) * | 2017-02-07 | 2021-10-07 | Sigma-Aldrich Co. Llc | Stable targeted integration |
CN107557390A (en) * | 2017-09-18 | 2018-01-09 | 江南大学 | A kind of method for screening the high expression sites of Chinese hamster ovary celI system |
CN107723276B (en) * | 2017-11-02 | 2021-08-13 | 上海交通大学 | Construction method and kit for cell strain of stable high-expression target product |
CN109295092B (en) * | 2018-10-30 | 2021-06-29 | 江南大学 | Application of NW _003613638-1 stable expression protein in CHO cell genome |
-
2018
- 2018-10-30 CN CN201811274637.4A patent/CN109295092B/en active Active
-
2019
- 2019-10-22 SG SG11202009389QA patent/SG11202009389QA/en unknown
- 2019-10-22 WO PCT/CN2019/112451 patent/WO2020088300A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN109295092A (en) | 2019-02-01 |
WO2020088300A1 (en) | 2020-05-07 |
CN109295092B (en) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202009389QA (en) | Use of nw_003613638.1 in cho cell genome for stable expression of protein | |
MX2019000205A (en) | Compositions and methods related to therapeutic cell systems expressing exogenous rna. | |
PH12019500709A1 (en) | Anti-lag-3 antibodies and methods of use thereof | |
CL2021001078A1 (en) | 2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors. | |
PH12018502645A1 (en) | Optimized mini-dystrophin genes and expression cassettes and their use | |
MX2022001222A (en) | Anti-tim-3 antibodies and methods of use thereof. | |
IL276715A (en) | Compositions and methods for membrane protein delivery | |
DK3737264T3 (en) | PORTABLE CHAIR | |
MA50746A (en) | FUSION PROTEINS INCLUDING SUBSTITUTIVE ENZYMOTHERAPY ENZYMES | |
SG11202010741WA (en) | Use of nw_006882456.1 in cho cell genome for stable expression of proteins | |
SG10201900003WA (en) | Non-human animals having a humanized b-cell activating factor gene | |
MA52542A (en) | ADOPTIVE CELL THERAPY | |
PH12016501689B1 (en) | Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof | |
SG11202109277WA (en) | Stable protein formulations | |
DK3429689T3 (en) | Acellular placental preparations | |
MX2020012893A (en) | Protein formulations. | |
IL277797A (en) | Methods for making stable protein compositions | |
ZA202006252B (en) | Yeast proteins | |
IL281088A (en) | Flt3l-based chimeric proteins | |
GB201619433D0 (en) | Hair care agents containing casein hydrolysate for improving hair structure | |
MX2020003626A (en) | Recombinant expression of pcv2b orf2 protein in insect cells. | |
PL3273909T3 (en) | Artificial descemet's membrane | |
IL279214A (en) | Therapeutic dosage regimens comprising adherent stromal cells | |
SG11202011353XA (en) | Stable fusion protein formulation | |
IS050214A (en) | Culture tank |